Alpha Diagnostic International, Inc. Human Dopamine beta hydroxylase (DBH) Control/blocking peptide # 2 DBH12-P

Human Dopamine beta hydroxylase (DBH) Control/blocking peptide # 2 General Information Dopamine beta hydroxylase (DBH) or Dopamine beta monooxygenase belongs to the copper type II, ascorbate-dependent monooxygenase family. DBH mediates conversion of dopamine to noradrenaline. It requires PQQ, copper, and ascorbate for enzyme activity. DBH SugApplications Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 18-aa peptide of human DBH (1) Designated (DBH12-P or control peptide) conjugated to KLH. Epitope location ~ N-terminal SpCrossreactivity Human DBH12-P peptide sequence is 83% conserved in mouse, rat, and bovine DBH. Anti-DBH reacts with-human, monkey, bovine, rat, and sheep DBH. Other species not tested. For research use only, not for diagnostic or therapeutic use.